focus -WSS

focus

author：fashion 2025-09-27 12:54:43 - browse：6246

Silver Apple Watch — Charles Rex Arbogast/AP

Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.

Rune in 2022 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication. The app also collects sleep, activity, and medication data and can serve as a focal point for education and care management for people with Parkinson’s. The app can help users make day-to-day decisions about lifestyle and medication and help inform care decisions by providers. Rune also works with drug companies developing treatments for the disease.

Rune Labs CEO Brian Pepin told STAT the company will use the funds to push the adoption of its technology among health plans that can use it to manage care for their members with Parkinson’s disease. The company last year finalized a deal with “a large California health system” and now hopes to go out and sell to more organizations that have Medicare Advantage plans or other at-risk populations they serve. This requires an investment in business development staff and people to manage those relationships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Merus drug and Keytruda shrank tumors in patients with head and neck cancer

knowledge

WSS

AstraZeneca loses challenge to Medicare drug price negotiation

Do more moles mean more problems? Not so, says new study

Covid isolation guidance eased by the CDC

Clinical trials giant ICON acquires HumanFirst

RaDonda Vaught to speak at CommonSpirit event on patient safety

Congress gives doctors Medicare pay bump

focus

focus

explore

Anesthesiologist group: stop taking Ozempic before surgery

Why getting cancer drugs just got harder for rural patients

After affirmative action ruling, medical educators look to 'holistic review'

Covid isolation guidance eased by the CDC

Walensky prepares to leave CDC — and Congress — behind

Adam's Biotech Scorecard: Do Sarepta's exon

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

entertainment

What will save rural psychiatry services? Higher Medicaid payments

Average age of first period drops to 11.9 years, study shows

How to fix the rural physician shortage in the U.S.

Scientists unlock the key to scar

Stigma and the return of syphilis

Addiction doctors spar with methadone clinics over legislation

focus

knowledge

knowledge

focus